Akanda Corporation Announces CFO Appointment LONDON

Corporation Announces CFO Appointment

December 11, 2023 - International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:

AKAN) an Ontario company, reported that it has appointed a new Chief Financial Officer. Effective immediately Charn Deol will join the

company and come to Akanda with more than 35 years of financial markets.

Board replaced on December 4th 2023, the current CFO with Charn Deol, a multi-industry executive with over 35 years of public

company management experience. Mr. Deol's recent experience includes being a director or in management of numerous Canadian private and

public companies including CEO of Bayridge Resources Inc., a director of Amber Brands Inc., Green Battery Minerals Inc., and Neotech

Metals Inc. He has been involved in initial IPOs being established which required taking private companies in Canada through the regulatory

process of going public.

Field, interim Chief Executive Officer and director, commented, "We welcome Charn to the team. This is a transitional yet promising

time for Akanda as we look to participate in the early-stage European and worldwide cannabis markets. His experience managing public

companies will provide the team with the requisite guidance needed to navigate this phase of our business."

is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to

high quality and affordable products. Akanda's portfolio includes Holigen, a Portugal-based cultivator, manufacturer and distributor

with a prized EU GMP certified indoor grow facility; and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which

supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships with California-based

Cookies, the most globally recognized cannabis company in the world; Cansativa Group, a leading importer and distributor of medical cannabis

in Europe; and Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK.

with Akanda: Email |

Saunders Irvine Partners

Note Regarding Forward-Looking Information and Statements

press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation

and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions

of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements

are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding

future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally,

such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans",

"expects" or "does not expect", "is expected", "budget", "scheduled", "estimates",

"forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations

of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would",

"might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking

information may relate to anticipated events or results including, but not limited to business strategy, product development and sales

and growth plans. The forward-looking information and forward- looking statements contained in this press release are made as of the

date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements

that are contained or referenced herein, except in accordance with applicable securities laws.